SCHEMBL6837744

SCHEMBL6837744

COc1cccc2cc(C(N)=O)oc12.c1cc2ccc1CN(C1CCCC1)C2

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.68
KMT2A Q03164 3/20 0.68
LMNA P02545 2/20 0.53
RECQL P46063 1/20 0.53
RAB9A P51151 4/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
NPC1 O15118 3/20 0.49
MEN1 O00255 2/20 0.49
CHRNA7 P36544 1/20 0.48
ADORA2A P29274 3/20 0.48
ADORA1 P30542 2/20 0.48
ADORA2B P29275 2/20 0.48
HTT P42858 3/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 4/20 0.46
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 2/20 0.46
CYP1A2 P05177 1/20 0.46
PKM P14618 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745478 0.82 KMT2A (1.00) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL6837986 0.82 ALDH1A1 (0.60) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL6837589 0.77 KMT2A (0.55) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL7427719 0.73 LMNA (0.68) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL6839051 0.73 ADORA2A (0.72) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL6839227 0.71 LMNA (0.64) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL219813 0.71 LMNA (1.00) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL978037 0.71 LMNA (0.77) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL6837609 0.71 ADORA2A (0.69) ALDH1A1KMT2ALMNARECQLRAB9A
SCHEMBL6837927 0.70 LMNA (0.63) ALDH1A1KMT2ALMNARECQLRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716987-B1 PHOSPHODIESTERASE IV INHIBITORS KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-04-06 US disclosed
US-6514996-B2 Derivatives of benzofuran or benzodioxole KYOWA HAKKO KOGYO CO., LTD. (JP) 2003-02-04 US disclosed
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE KYOWA HAKKO KOGYO CO., LTD. (JP) 2002-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020128290-A1 DERIVATIVES OF BENZOFURAN OR BENZODIOXOLE CBR1, CBR3, CYC1 ALDH1A1 323/4885KMT2A 4289/4885LMNA 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.